CRISPR-Cas9 dissection of heparan sulfate

被引：0
|
作者：
Weiss, Ryan J.
Spahn, Philipp N.
Lewis, Nathan E.
Esko, Jeffrey D.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-5945
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5945
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CRISPR-Cas9 Dissection of Heparan Sulfate
    Weiss, Ryan J.
    Spahn, Philipp N.
    Lewis, Nathan E.
    Esko, Jeffrey D.
    [J]. GLYCOBIOLOGY, 2017, 27 (12) : 1211 - 1211
  • [2] The MyLO CRISPR-Cas9 toolkit: a markerless yeast localization and overexpression CRISPR-Cas9 toolkit
    Bean, Bjorn D. M.
    Whiteway, Malcolm
    Martin, Vincent J. J.
    [J]. G3-GENES GENOMES GENETICS, 2022, 12 (08):
  • [3] Engineering Genes with CRISPR-Cas9
    Luo, Michelle L.
    Beisel, Chase L.
    [J]. CHEMICAL ENGINEERING PROGRESS, 2016, 112 (09) : 36 - 41
  • [4] Putting the brakes on CRISPR-Cas9
    Todorovic, Vesna
    [J]. NATURE METHODS, 2017, 14 (02) : 108 - 108
  • [5] CRISPR-Cas9: a world first?
    不详
    [J]. LANCET, 2018, 392 (10163): : 2413 - 2413
  • [6] Nanoparticles for CRISPR-Cas9 delivery
    Glass, Zachary
    Li, Yamin
    Xu, Qiaobing
    [J]. NATURE BIOMEDICAL ENGINEERING, 2017, 1 (11): : 854 - 855
  • [7] Protein Inhibitors of CRISPR-Cas9
    Bondy-Denomy, Joseph
    [J]. ACS CHEMICAL BIOLOGY, 2018, 13 (02) : 417 - 423
  • [8] In vivo dissection and correction of the tyrosine catabolic pathway using CRISPR-Cas9
    Rivest, J. F.
    Carter, S.
    Goupil, C.
    Cyr, D.
    Ung, R. V.
    Soglio, D. D.
    Mac-Way, F.
    Waters, P. J.
    Paganelli, M.
    Doyon, Y.
    [J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A145 - A145
  • [9] The invisible dance of CRISPR-Cas9
    Palermo, Giulia
    Ricci, Clarisse G.
    McCammon, J. Andrew
    [J]. PHYSICS TODAY, 2019, 72 (04) : 30 - 36
  • [10] CRISPR-Cas9 in cancer therapeutics
    Randhawa, Shubhchintan
    [J]. REPROGRAMMING THE GENOME: CRISPR-CAS-BASED HUMAN DISEASE THERAPY, 2021, 181 : 129 - 163
12345